IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically urine) to determine nuclear mitotic apparatus protein (NMP), a protein that makes up the internal structure of the nucleus (i.e., a nuclear matrix protein) and is usually known as NMP22. Increased levels of NMP22 are found in urine of patients with transitional cell carcinoma of the urinary tract.

Entry Terms : "Nuclear Matrix Protein (NMP22) Determination Reagents" , "NMP22 (Nuclear Matrix Protein 22) Determination Reagents" , "Reagents, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)"

UMDC code : 19855

U.S.companies only
Suppress Subsidiary Companies

1-1 of 1 Match(es).

PerkinElmer Inc

Company Type: Parent

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world.

1-1 of 1 Match(es).

Medical Product Guide OBG Management Product Zone